Pharmaceutical products for the treatment of neurological diseases and disorders; pharmaceutical products for the treatment of autoimmune diseases and disorders; pharmaceutical products for the treatment of multiple sclerosis (MS); pharmaceutical products for the treatment of relapsing forms of multiple sclerosis (MS); pharmaceutical products for the treatment of clinically isolated syndrome; pharmaceutical products for the treatment of relapsing-remitting multiple sclerosis (MS) disease; pharmaceutical products for the treatment of active secondary progressive multiple sclerosis (MS) disease

'activ':70 'autoimmun':17 'clinic':48 'diseas':8,18,63,76 'disord':10,20 'form':37 'isol':49 'ms':29,41,62,75 'multipl':27,39,60,73 'neurolog':7 'pharmaceut':1,11,21,30,42,51,64 'product':2,12,22,31,43,52,65 'progress':72 'relaps':36,58 'relapsing-remit':57 'remit':59 'sclerosi':28,40,61,74 'secondari':71 'syndrom':50 'treatment':5,15,25,34,46,55,68

DOFUMARTA

Owners

Goods & Services